X

Tirzepatide 10 mg

100,00 

Tirzepatide is a synthetic dual receptor agonist peptide supplied in lyophilized powder form for laboratory research. Commonly investigated in studies of incretin receptor signaling, glucose metabolism, and metabolic pathway regulation. Delivered as a 10 mg sterile lyophilized preparation in a sealed research vial.

In stock

Category:

Description

Research peptide targeting GLP-1 and GIP pathways for weight loss

Product overview

Tirzepatide is a dual GIP/GLP-1 receptor agonist widely studied in metabolic and weight-regulation research. Its dual-pathway mechanism makes it a powerful candidate for studies related to appetite modulation, glucose control, and obesity interventions.

Key benefits (anecdotal & research-based)

Studied for potent appetite suppression and weight-loss effects.
Investigated for improvement of insulin sensitivity and glucose control.
Potential metabolic benefits beyond traditional GLP-1 analogues.
Research interest in cardiovascular and liver-health markers.
Dual receptor activity may produce broader metabolic outcomes.

Product characteristics

Purity: ≥98% (HPLC-tested)
Appearance: Lyophilized white/off-white powder
Molecular formula: C225H348N48O68
Molecular weight: 4813.45
Sequence: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(AEEA-AEEA-γ-Glu-C20 diacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
Storage: store lyophilized powder at -20°C, protect from light and moisture. Reconstituted solution should be kept at 2–8°C and used within a short period.

Why choose our Tirzepatide?

≥ 98% purity verified by HPLC.
Produced in GMP-compliant facilities under strict QC protocols.
Each batch carefully lab tested after production (you can find Certificate of Analysis under product pictures).
Freeze-dried (lyophilized) for maximum stability and extended shelf life.
Sealed in sterile vials, ready for reconstitution.
Reconstitution: Must be reconstituted with bacteriostatic water before use. GLP-1 class peptides are sometimes slow to dissolve and require very gentle reconstitution to avoid foaming or remaining slightly cloudy.

Related research context

Tirzepatide is part of the dual incretin receptor agonist (GLP-1/GIP) metabolic research class. For mechanistic comparison with single-pathway GLP-1 agonists and triple-agonist compounds, see our GLP-1 metabolic research guide.

Browse all compounds in the Metabolic research category.

Researchers comparing multi-receptor activation may also examine:

NOTE: This is for educational reference only and does not constitute medical advice.

Disclaimer:
This product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide 10 mg”

Your email address will not be published. Required fields are marked *

Related products